Drug Discovery

A groundbreaking study led by scientists at The Wistar Institute marks a significant leap forward in the decades-long search for an effective HIV vaccine, demonstrating that a novel vaccine candidate can induce neutralizing antibodies after just a single immunization in nonhuman primates. This

The successful conclusion of cancer treatment should be a moment of pure triumph, yet for many, it signals the start of a lifelong struggle with chronic, painful tissue damage—a silent epidemic born from the very therapy that saved them. While radiotherapy stands as a pillar of modern oncology, its

As a Biopharma expert at the forefront of tech and innovation, Ivan Kairatov is revolutionizing how we study the human brain. His work focuses on developing advanced, human-relevant models known as brain microphysiological systems to enhance the safety of chemical and drug testing. In our

In the persistent global battle against obesity, a new front has opened that shifts focus from the brain's appetite signals to a previously hard-to-study type of fat tissue within our own bodies. Insitro, a therapeutics company leveraging artificial intelligence for biological discovery, has

For decades, the field of oncology has striven for precision, tailoring therapies to the unique genetic fingerprint of a tumor, yet a fundamental biological variable present in every cell of a patient's body has been largely overlooked: their sex. A groundbreaking study now challenges this

In a move that sends ripples across the global pharmaceutical landscape, AstraZeneca has committed to a landmark $15 billion investment in China, a strategic initiative designed to run through 2030. The announcement, made on January 29, 2026, signals a profound deepening of the company's research,